Camlin Fine Sciences narrows standalone loss as consolidation gains hit
The company reported a consolidated net profit of ₹2,762.72 lakh for FY26, buoyed by the liquidation of its European subsidiary and the integration of Vinpai.
— 3 earlier stories on Camlin Fine Sciences Ltd. →What's new
- Standalone net loss narrowed to ₹3,296.62 lakh from ₹7,631.05 lakh in the prior year.
- Consolidated profit was driven by the liquidation of CPS Europe SpA and the inclusion of Vinpai.
- The board appointed a new CFO and re-designated the current CFO.
Why this matters
The shift to a consolidated profit is heavily dependent on one-time liquidation gains rather than core operational performance. Management changes at the CFO level add a layer of transition risk to the company's financial oversight.
What we're watching
- Whether the core business can sustain profitability without liquidation gains.
- The impact of the new CFO on financial reporting and strategy.
- Integration progress of the Vinpai acquisition.
The full read
Camlin Fine Sciences reported audited results for FY26, showing a narrowed standalone net loss of ₹3,296.62 lakh compared to the prior year's ₹7,631.05 lakh. On a consolidated basis, the company posted a net profit attributable to owners of ₹2,762.72 lakh.
This bottom-line result relies on the liquidation of its subsidiary, CPS Europe SpA, and the recent inclusion of Vinpai. Alongside the financials, the board shuffled its finance leadership by appointing a new CFO and re-designating the incumbent.
Reliance on non-recurring gains to reach profitability suggests the underlying business remains under pressure. Investors should look past the headline profit to determine if the core operations are actually gaining traction. It is a tall order.
Questions answered
- What drove the consolidated profit for the year?
- The profit of ₹2,762.72 lakh was primarily driven by a gain from the liquidation of CPS Europe SpA and the inclusion of Vinpai.
- How did the standalone performance compare to the previous year?
- The standalone net loss improved to ₹3,296.62 lakh, down from a loss of ₹7,631.05 lakh in the prior year.
- What management changes were announced?
- The board approved the appointment of a new CFO and the re-designation of the current CFO.
Story so far
All notes on CAMLINFINE →- 26 May 2026 · 4:58 PM IST Camlin Fine Sciences narrows standalone loss as consolidation gains hit
- 1d ago Camlin Fine Sciences blames logistics and phenol costs for sales hit
- 4d ago Camlin Fine Sciences cuts vanillin price guidance as costs surge
- 4d ago Camlin Fine Sciences narrows standalone loss to ₹3,296.62 lakh